₹524
(Inclusive of all Taxes)
₹78.6 Cashback (15%)
coupon
Prescription drugWhats That
Composition :
Manufacturer/Marketer :
Consume Type :
Return Policy :
Expires on or after :
Secure Payment
Trusted by 8 Crore Indians
Genuine Products
Author Details
Disclaimer
Alcohol
Unsafe
It is advisable not to consume alcohol along with Enpag 10 mg Tablet to avoid unpleasant side effects like lactic acidosis.
Pregnancy
Caution
Enpag 10 mg Tablet is not recommended during pregnancy. However, your doctor may prescribe it for you during pregnancy if he/she feels the benefit outweighs the risk. You should not take Enpag 10 mg Tablet without a doctor's advice.
Breast Feeding
Unsafe
Enpag 10 mg Tablet is not recommended if you are breastfeeding or if you are planning to breastfeed your baby.
Driving
Safe if prescribed
Enpag 10 mg Tablet should not affect your ability to drive or operate machinery/tools.
Liver
Caution
Enpag 10 mg Tablet to be taken with caution, especially if you have a history of liver diseases/conditions. The dose may have to be adjusted by your doctor.
Kidney
Caution
Enpag 10 mg Tablet to be taken with caution, especially if you have a history of Kidney diseases/conditions. The dose may have to be adjusted by your doctor depending on your renal functions. Enpag 10 mg Tablet is not recommended in severe kidney disease. Regular monitoring of kidney function tests is therefore important if you're taking Enpag 10 mg Tablet .
Children
Safe if prescribed
Enpag 10 mg Tablet is not recommended for children below ten years of age. The dose is to be adjusted and recommended by a child specialist only for children over ten years.
Product Substitutes
Drug-Drug Interactions
Drug-Drug Interactions
Login/Sign Up
Coadministration of Enpag 10 mg Tablet with Gatifloxacin may sometimes affect blood glucose levels. Both high blood glucose and, less frequently, low blood glucose have been reported.
How to manage the interaction:
It is not recommended to take Enpag 10 mg Tablet with Gatifloxacinas it can result in an interaction, but it can be taken if advised by the doctor. Consult the prescriber if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremors, nausea, hunger, weakness, perspiration, palpitation, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised. Do not discontinue any medication without consulting a doctor.
Combining Mecamylamine with Enpag 10 mg Tablet can increase the risk of side effects like dehydration and low blood pressure.
How to manage the interaction:
Although taking Mecamylamine and Enpag 10 mg Tablet together can cause an interaction, it can be taken if your doctor has suggested it. If you notice any of these signs like feeling very thirsty, having low blood pressure, a headache, feeling dizzy or lightheaded, or even fainting, make sure to contact a doctor right away. Do not stop using any medications without talking to a doctor.
Drug-Food Interactions
Drug-Food Interactions
Login/Sign Up
Drug-Diseases Interactions
Drug-Diseases Interactions
Login/Sign Up
In patients with decreasing renal function, the glucose-lowering benefits of sodium-glucose cotransporter 2 (SGLT2) inhibitors are reduced. In addition, those who have impaired renal function (eGFR less than 60 mL/min/1.73 m2), those who are old, and those on loop diuretics may be more susceptible to deleterious effects of volume depletion such hypotension and acute kidney damage. Prior to starting therapy, at-risk individuals should have their renal function assessed, and it should be followed up on often. Before starting treatment, determine the volume status and address volume depletion. It is not recommended to use SGLT-2 inhibitors in dialysis patients. SGLT2 inhibitor medication has been shown to have positive benefits on chronic renal disease and heart failure in persons with and without type 2 diabetes. The product labelling from the manufacturer has to be
How to manage the interaction:
Enpag 10 mg Tablet is contraindicated in patients undergoing dialysis.
Sodium-glucose cotransporter 2 (SGLT-2) inhibitors produce intravascular volume contraction, which may result in symptomatic hypotension following the start of medication, particularly in older patients, those with impaired renal function, those with low systolic blood pressure, and those using diuretics. Prior to beginning treatment, the volume status should be evaluated, rectified, and patients should be monitored closely.
How to manage the interaction:
Blood plasma volume should be assessed and corrected before starting treatment with Enpag 10 mg Tablet and patients should be monitored during therapy.
The usage of sodium-glucose cotransporter 2 (SGLT-2) inhibitors has been associated with an increased risk of genital mycotic infections. When administering this medication to patients who have a history of genital mycotic infections or who have not had circumcision, caution should be used since they are more susceptible to get genital mycotic infections. Observe and treat as necessary.
How to manage the interaction:
Enpag 10 mg Tablet should be used with caution in patients who have a history of genital mycotic infections (fungal infections of the urogenital area) or who are uncircumcised as these patients are more likely to develop genital mycotic infections.
Have a query?